Use of perfluorocarbon liquids, silicone oil, and 5-fluorouracil in the management of experimental PVR

International Ophthalmology

Volumn 22, Issue 4, 1998, Pages 239-246

  Hegazy, Hassan M ^a,b   Peyman, Gholam A ^a,c   Liang, Chanping ^a   Unal, Melih H ^a   Molinari, Luiz C ^a   Kazi, Abdul A ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AL AZHAR UNIVERSITY   (Egypt)

^c LSU EYE CENTER   (United States)

Author keywords

5 Fluorouracil; Perfluoroperhydrophenanthrene; Proliferative vitreoretinopathy; Silicone oil; Vitrectomy

Indexed keywords

FLUOROURACIL; PERFLUOROPHENANTHRENE; SILICONE OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EYE INFLAMMATION; EYE TOXICITY; NONHUMAN; RABBIT; VITRECTOMY; VITREORETINOPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ELECTRORETINOGRAPHY; FLUOROCARBONS; FLUOROURACIL; INJECTIONS; RABBITS; RETINA; SILICONE OILS; TREATMENT OUTCOME; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0032232305     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006336831730     Document Type: Article

References (30)

1. The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121-125.
2. Peyman GA, Schulman JA. Intravitreal surgery: principles and practice. 2nd ed. Norwalk, CT: Appleton & Lange, 1994.
3. Rachal WF, Burton TC. Changing concepts of failure after retinal detachment surgery. Arch Ophthalmol 1979; 97: 480-483.
4. Machemer R. Proliferative vitreoretinopathy (PVR): A personal account of its pathogenesis and treatment. Invest Ophthalmol Vis Sci 1988; 29: 1771-1783.
5. Peyman GA, Conway MD, Soike KF, Clark LC Jr. Long-term vitreous replacement in primates with intravitreal Vitreon or Vitreon plus silicone. Ophthalmic Surg 1991; 22: 657-664.
6. Sparrow JR, Jayakumar A, Berrocal M, Ozmert E, Chang S. Experimental studies of the combined use of vitreous substitutes of high and low specific gravity. Retina 1992; 12: 134-140.
7. Borhani H, Peyman GA, Rahimy MH, Thompson H. Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU. Int Ophthalmol 1995; 19: 43-49.
8. Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol 1980; 89: 131-136.
9. Blumenkranz MS, Ophir A, Claflin AJ, Hajek A. Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 1982; 94: 458-467.
10. Blumenkranz M, Hernandez E, Ophir A, Norton EWD. 5-fluorouracil: New applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 1984; 91: 122-130.
11. Koutsandrea CN, Miceli MV, Peyman GA, Farahat HG, Niesman MR. Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. Curr Eye Res 1991; 10: 249-258.
12. Chen EP, Steinhorst UH, Samsa GP, Saloupis PT, Hatchell DL. The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1992; 33: 2160-2164.
13. Barrada A, Peyman GA, Greenberg D, Stelmack T, Fiscella R. Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg 1983; 14: 845-847.
14. Stern WH, Fisher SK, Anderson DH, Lewis GP, Guerin CJ, Erickson PA, et al. Intraocular 5-fluorouracil therapy of experimental massive periretinal proliferation [abstract]. Invest Ophthalmol Vis Sci 1982; 22 Suppl: 234.
15. Fastenberg DM, Diddie KR, Dorey K, Ryan SJ. The role of cellular proliferation in an experimental model of massive periretinal proliferation. AmJ Ophthalmol 1982; 93: 565-572.
16. Scott JD. The treatment of massive vitreous retraction. Trans Ophthalmol Soc UK 1973; 93: 417-423.
17. Fastenberg D, Delmage J, Dorey K, Diddie KR. Experimental massive periretinal proliferation: The effect of silicone oil [abstract]. Invest Ophthalmol Vis Sci 1982; 22 Suppl: 233.
18. Scott JD. The treatment of massive vitreous retraction by the separation of pre-retinal membranes using liquid silicone. Mod Probl Ophthalmol 1975; 15: 185-190.
19. Peyman GA, Schulman JA. Vitreous substitutes. Norwalk, CT: Appleton & Lange, 1995.
20. Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Arch Ophthalmol 1992; 110: 770-779.
21. Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Arch Ophthalmol 1992; 110: 780-792.
22. Clark LC Jr, Gollan F. Survival of mammals breathing organic fluids equilibrated with oxygen at atmospheric pressure [letter]. Science 1966; 152: 1755-1756.
23. Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM. Fluorinated oils as experimental vitreous substitutes. Arch Ophthalmol 1986; 104: 1053-1056.
24. Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM. Perfluoroether liquid as a long-term vitreous substitute: An experimental study. Retina 1984; 4: 264-268.
25. Gremillion CM Jr, Peyman GA, Liu KR, Naguib KS. Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 1990; 74: 643-646.
26. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987; 103: 38-43.
27. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988; 106: 668-674.
28. Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, et al. Experimental evaluation of perfluoroperhydrophenanthrene as a high specific gravity vitreous substitute: A preliminary report. Ophthalmic Surg 1989; 20: 286-293.
29. Bottoni MF, Sborgia M, Vinciguerra P, Zenoni S, De Molfetta V. Perfluorodecalin (PFD) and perfluoroperhydrophenanthrene (PFP) as post-operative short-term vitreous substitutes. J Vitreo Retina 1992; 1: 37-41.
30. Tanji TM, Peyman GA, Mehta NJ, Millsap CM. Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery. Ophthalmic Surg 1992; 24: 681-685.